FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35142111000001101: Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1613081000001114 Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1613091000001111 Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Is a Doxazosin 2mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has AMP Doxazosin 2mg tablets (Milpharm Ltd) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier 1
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength numerator value 2 false Inferred relationship Existential restriction modifier 1
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start